The anti-interleukin-6 antibody siltuximab down-regulates genes implicated in tumorigenesis in prostate cancer patients from a phase I study.
Related Research units
Abstract
Bibliographical data
Original language | English |
---|---|
Article number | 13 |
ISSN | 0270-4137 |
Publication status | Published - 2011 |
pubmed | 21321981 |
---|